Vidal-Vanaclocha F - Search Results

1

Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis.

Badiola I, Olaso E, Crende O, Friedman SL, Vidal-Vanaclocha F. Badiola I, et al. Gut. 2012 Oct;61(10):1465-72. doi: 10.1136/gutjnl-2011-300810. Epub 2011 Nov 9. Gut. 2012. PMID: 22071959

2

Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis.

Olaso E, Salado C, Egilegor E, Gutierrez V, Santisteban A, Sancho-Bru P, Friedman SL, Vidal-Vanaclocha F. Olaso E, et al. Hepatology. 2003 Mar;37(3):674-85. doi: 10.1053/jhep.2003.50068. Hepatology. 2003. PMID: 12601365

3

IL-18 regulates melanoma VLA-4 integrin activation through a Hierarchized sequence of inflammatory factors.

Valcárcel M, Carrascal T, Crende O, Vidal-Vanaclocha F. Valcárcel M, et al. J Invest Dermatol. 2014 Feb;134(2):470-480. doi: 10.1038/jid.2013.342. Epub 2013 Aug 12. J Invest Dermatol. 2014. PMID: 23938462 Free article.

4

Endostatin inhibits murine colon carcinoma sinusoidal-type metastases by preferential targeting of hepatic sinusoidal endothelium.

Solaun MS, Mendoza L, De Luca M, Gutierrez V, López MP, Olaso E, Lee Sim BK, Vidal-Vanaclocha F. Solaun MS, et al. Hepatology. 2002 May;35(5):1104-16. doi: 10.1053/jhep.2002.32528. Hepatology. 2002. PMID: 11981760

5

Resveratrol prevents inflammation-dependent hepatic melanoma metastasis by inhibiting the secretion and effects of interleukin-18.

Salado C, Olaso E, Gallot N, Valcarcel M, Egilegor E, Mendoza L, Vidal-Vanaclocha F. Salado C, et al. J Transl Med. 2011 May 12;9:59. doi: 10.1186/1479-5876-9-59. J Transl Med. 2011. PMID: 21569399 Free PMC article.

6

Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.

Crende O, Sabatino M, Valcárcel M, Carrascal T, Riestra P, López-Guerrero JA, Nagore E, Mandruzzato S, Wang E, Marincola FM, Vidal-Vanaclocha F. Crende O, et al. Am J Pathol. 2013 Jul;183(1):69-82. doi: 10.1016/j.ajpath.2013.03.026. Epub 2013 May 23. Am J Pathol. 2013. PMID: 23707237

7

Use of tumor-activated hepatic stellate cell as a target for the preclinical testing of anti-angiogenic drugs against hepatic tumor development.

Olaso E, Vidal-Vanaclocha F. Olaso E, et al. Methods Mol Med. 2003;85:79-86. doi: 10.1385/1-59259-380-1:79. Methods Mol Med. 2003. PMID: 12710199 Review. No abstract available.

8

Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2.

Valcárcel M, Mendoza L, Hernández JJ, Carrascal T, Salado C, Crende O, Vidal-Vanaclocha F. Valcárcel M, et al. J Transl Med. 2011 Aug 25;9:142. doi: 10.1186/1479-5876-9-142. J Transl Med. 2011. PMID: 21867538 Free PMC article.

9

Mannose receptor-mediated endothelial cell activation contributes to B16 melanoma cell adhesion and metastasis in liver.

Mendoza L, Olaso E, Anasagasti MJ, Fuentes AM, Vidal-Vanaclocha F. Mendoza L, et al. J Cell Physiol. 1998 Mar;174(3):322-30. doi: 10.1002/(SICI)1097-4652(199803)174:3<322::AID-JCP6>3.0.CO;2-Q. J Cell Physiol. 1998. PMID: 9462694

10

Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis.

Olaso E, Santisteban A, Bidaurrazaga J, Gressner AM, Rosenbaum J, Vidal-Vanaclocha F. Olaso E, et al. Hepatology. 1997 Sep;26(3):634-42. doi: 10.1002/hep.510260315. Hepatology. 1997. PMID: 9303493

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters